GlassScriptPhysician profile
Peter Brian Walimire
NPI 1518288778
$18,546.28
in general payments reported to CMS, 2019-2025
36 companies · $5,568 in 2025
The $5,568 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,480 · 2020: $1,704 · 2021: $1,320 · 2022: $4,573 · 2023: $3,319 · 2024: $582 · 2025: $5,568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,437 · Consulting Fee: $2,800 · Food and Beverage: $2,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,437.40 |
| Consulting Fee | $2,800.00 |
| Food and Beverage | $2,232.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $4,503.90 | 2022-2025 | |
| Biopro, INC. | $4,189.91 | 2021-2025 | Hemi Toe |
| Arthrex, INC. | $3,345.74 | 2019-2021 | |
| Fusion Orthopedics, LLC. | $2,854.26 | 2020-2023 | |
| Acumed LLC | $1,102.59 | 2024-2025 | Osteomed, Acumed, Acumed |
| Smith+Nephew, INC. | $370.47 | 2019-2024 | Grafix Pl, Stravix, Grafix |
| Integra Lifesciences Corporation | $365.45 | 2019-2023 | Biofix, Biodoptix, Biodrestore |
| Convatec INC. | $288.20 | 2023-2024 | |
| Stryker Corporation | $179.13 | 2019-2021 | |
| Orthofix Medical, INC. | $174.18 | 2020-2025 | Physio-Stim, Accelstim |
| Paratek Pharmaceuticals, INC. | $161.55 | 2023-2025 | Nuzyra |
| Horizon Therapeutics Plc | $134.41 | 2021-2022 | |
| Wright Medical Technology, INC. | $129.83 | 2019 | |
| Treace Medical Concepts, INC. | $109.02 | 2024-2025 | |
| Biopoly LLC | $66.66 | 2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $58.73 | 2022-2023 | Puraply |
| Ossio INC | $57.71 | 2021 | |
| Next Science LLC | $52.38 | 2023-2024 | Xperience, Surgx, Blastx |
| Ermi LLC | $40.25 | 2019-2020 | |
| Metric Medical Devices, INC. | $39.89 | 2022 | |
| Anika Therapeutics, INC. | $32.02 | 2023 | Toe Motion, Tactoset |
| Depuy Synthes Sales INC. | $30.24 | 2023 | Motoband |
| Reprise Biomedical, INC. | $29.98 | 2023 | Miro3d |
| Triad Life Sciences INC. | $24.20 | 2022 | |
| Bioventus LLC | $24.02 | 2022 | |
| Trice Medical, INC. | $21.79 | 2023 | |
| Flower Orthopedics Coporation | $20.66 | 2023 | |
| Grt US Holding, INC. | $18.25 | 2022 | |
| Curonix LLC | $18.19 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $16.41 | 2022 | |
| Solventum Corporation | $16.34 | 2024 | Prevena |
| Coastal Medical Technologies LLC | $16.01 | 2023 | |
| Novastep INC. | $14.76 | 2021 | |
| Medtronic, INC. | $14.64 | 2023 | Intellis Adaptivestim |
| Kci USA, INC. | $14.09 | 2021 | |
| Polymedics Innovations INC. | $10.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Walimire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.